Senior Vice President, Regulatory Affairs
Ingrid Hoos is responsible for Regulatory Affairs and Medical Affairs activities at Eton.
Ms. Hoos has more than 35 years of experience in biomedical and pharmaceutical regulatory affairs and product development. She has been responsible for the development of global regulatory strategies for numerous new chemical entities and medical devices resulting in direct experience with regulatory agencies in the U.S., Europe, Canada, and Japan.
Prior to joining Eton Pharmaceuticals, Ms. Hoos served as Vice President, Regulatory Affairs at Horizon Therapeutics for 9 years. Prior experiences included regulatory and product development roles at Takeda, Searle (Pfizer), and Baxter Healthcare